6 terminated. 6 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Terminated 6 |
| Phase 1 | 1 | Terminated 1 |
Follow Metastases: new trials by email Literature Review of Metastases trials Research Report on Metastases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Chemoradiotherapy for Patients With Oligometastatic Colorectal Cancer Capecitabine, Bevacizumab, Radiotherapy - Colorectal Cancer, Metastases | Phase 2 | Terminated | Universitätsklinikum Hamburg-Eppendorf | 1 | 2013-05-01 | 2022-07-01 |
| Pre- and Post-operative FOLFOX Based Therapy for Patients With Colorectal Cancer With Liver Involvement Cetuximab, Bevacizumab, Leucovorin - Colorectal Cancer, Metastases | Phase 2 | Terminated | Washington University School of Medicine | 9 | 2007-06-01 | 2016-12-20 |
| Irinotecan Discontinuation and Reintroduction for Advanced Colorectal Cancer Irinotecan - Colorectal Neoplasms, Metastases | Phase 2 | Terminated | Gachon University Gil Medical Center | 72 | 2005-04-01 | 2008-11-25 |
| Using TRAP to Evaluate the Effect of Zometa on Bone Metastasis Due to Lung Cancer zoledronic acid - Carcinoma, Non-Small Cell Lung, Carcinoma, Small Cell Lung | Phase 2 | Terminated | University of Louisville | 28 | 2005-02-01 | 2018-03-05 |
| Safety and Activity of 90Y-Labeled IDEC-159 in Subjects With Metastatic Colorectal Adenocarcinoma Unconjugated IDEC-159, 111In-IDEC-159, 90Y-IDEC-159 - Colorectal Cancer, Metastases | Phase 1 / Phase 2 | Terminated | Biogen | 30 | 2005-01-01 | 2010-08-27 |
| Study of M200 (Volociximab) in Patients With Metastatic Renal Cell Carcinoma (RCC) Volociximab (anti-α5β1 integrin monoclonal antibody) - Renal Cell Carcinoma, Metastases | Phase 2 | Terminated | Abbott | 48 | 2005-01-01 | 2012-04-27 |
Neoplasm Metastasis (6) · Colorectal Neoplasms (4) · Carcinoma (1) · Carcinoma, Non-Small-Cell Lung (1) · Carcinoma, Renal Cell (1) · Lung Neoplasms (1) · Neoplasms (1) · Small Cell Lung Carcinoma (1)
Neoplasms by Site (6) · Neoplastic Processes (6) · Pathologic Processes (6) · Pathological Conditions, Signs and Symptoms (6) · Neoplasms (5) · Colonic Diseases (4) · Digestive System Diseases (4) · Digestive System Neoplasms (4) · Gastrointestinal Diseases (4) · Gastrointestinal Neoplasms (4) · Intestinal Diseases (4) · Intestinal Neoplasms (4) · Rectal Diseases (4) · Adenocarcinoma (1) · Bronchial Neoplasms (1)
Bevacizumab (2) · Capecitabine (1) · Cetuximab (1) · Fluorouracil (1) · Irinotecan (1) · Leucovorin (1) · Oxaliplatin (1) · Radiotherapy (1) · Zoledronic Acid (1) · volociximab (1)
Abbott (1) · Biogen (1) · Gachon University Gil Medical Center (1) · University of Louisville (1) · Universitätsklinikum Hamburg-Eppendorf (1) · Washington University School of Medicine (1)
United States (4) · Germany (1) · South Korea (1)
Andres Forero, M.D. (1) · Cordula Petersen, Prof. (1) · David Linehan, M.D. (1) · Goetz H Kloecker, MD, MSPH (1) · Mihail Obrocea, MD (1) · Se Hoon Park, MD (1)